Antibiotic resistance
While there are many challenges in clinical infectious disease management [1] , e.g., identifying the species of an isolates, testing its properties, such as resistance to antibiotics and virulence, and monitoring the emergence and spread of bacterial pathogens, here we will focus our discussion upon antibiotic resistance. The antimicrobial resistance is the resistance of a microorganism to an antimicrobial drug, such as antibiotics, that was originally effective for treatment of infections caused by it. Resistant microorganisms are able to withstand attack by antibiotic, so that standard treatments become ineffective and infections persist, increasing the risk of spread to others.
The evolution of resistant strains is a nature phenomenon that occurs when microorganisms replicate themselves erroneously or when resistant traits are exchanged between them. The use and misuse of antimicrobial drugs accelerates the emergence of drug-resistant strains. Poor infection control practices, inadequate sanitary conditions, and inappropriate food-handling encourage the further spread of antimicrobial resistance. Without effective anti-infective treatment, many standard medical treatments will fail or turn into vary high risk procedures. Infections caused by resistant microorganisms often fail to respond to the standard treatment, resulting in prolonged illness, higher health care expenditures, and a greater risk of death and spreading resistant microorganisms to others.
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Figure 10.1 First-line TB drugs (Credits: National Institute of Allergies and Infectious Diseases)
This chapter will use the bacterium Mycobacterium tuberculosis (MTB) as an example throughout. This is due to the relatively straightforward nature of the MTB genome and the pressing public health concerns worldwide associated with MTB drug resistance. Tuberculosis (TB), caused by the MTB bacterium, infects over onethird of the human population and claims over one million lives each year [1] . While TB caused by a drug-susceptible bacterium is completely curable through antibiotics, drug resistance is increasing worldwide; there was nearly a doubling of diagnosed multi-drug resistant (MDR)-TB cases from 2011 to 2012 [2] . As warned in a 2014 WHO report, "drug-resistant TB threatens global TB control and is a major public health concern in several countries" [3] . Figure 10 .1 shows how the most widely used antibiotics for TB, including isoniazid (INH), rifampicin (RIF), ethambutol (EMB), and Pyrazinamide (PZA). These drugs are used in first-line treatment for TB. MDR-TB is defined as being resistant to the most effective first-line antibiotics, which are INH and RIF. MDR now accounts for about 3.6% of all new TB cases and 20.2% of all previously treated cases worldwide. About 10% of these MDR cases are extensively drug-resistant, which is defined as also resistant to two different classes of second-line drugs [3] . Recently, there have been reports in India and Iran of totally drug-resistant MTB, in which the pathogens were not susceptible to any of the existing first-or second-line drugs, leaving only experimental treatment options [4] .
Susceptibility test to antibiotics
Determining the drug susceptibility profile, or antibiogram, of a new bacterial isolate is of paramount importance in order to prescribe appropriate drugs. Otherwise, the prescribed drugs will not cure the patient, the patient may develop further resistance, and the patient will go on spreading the (possibly now MDR) infection to others. Current methods for testing susceptibility include phenotypic and genotypic methods.
A schematic representation of the current workflow for processing samples for bacterial pathogens is presented in Figure 10 .2, showing high complexity and a typical timescale of a few weeks to a few months. In the case of MTB, phenotypic methods involve growing the MTB isolate in media impregnated with antibiotics. The goldstandard phenotypic method is the "proportion method" on sloped Löwenstein-Jensen (LJ) solid media [5] . This method, performed in specialised reference labs, compares bacterial growth with and without the presence of an antibacterial drug. However, MTB's slow growth-rate means that the LJ proportion method can require up to 2 months to obtain results. The concentration of the drug in the media and the critical proportion of colonies that grow in the antibiotic-impregnated media in order to call the bacteria "resistant" are established based upon clinically defined cut-offs. This produces binary resistant or susceptible labels.
Bacterial drug resistance arises due to mutations in the bacterial genome that enable it to avoid damage caused by the antibiotic. A single nucleotide polymorphism (SNP) is a single-base change in the DNA. Several such resistance-conferring mechanisms are known, and genotypic line-probe assays have been developed to identify the presence of known SNPs in a bacterial sample The "MTBDRplus" is a line-probe assay created by Hain (Germany), which tests for the primary mutations associated with resistance to INH and RIF. The Cepheid (USA) "Xpert" system is able to detect resistance to RIF within 2 h. However, these methods only are available for a subset of antibiotics, require further testing to confirm their results, and only probe for the most common resistance-conferring mutations. A much more flexible approach lies in the incorporation of whole genome sequencing (WGS) into the clinical diagnostic pathway [1] , which offers the opportunity to identify the presence of any known mutation in a bacterial sequence with a single assay. WGS differs from the genotypic methods presented above in that it reveals all of the SNPs in a given sample using a single test. Currently available sequencing methods require only about 2 days for complete processing (after growing the sample in culture for 7-10 days), with this time requirement only continuing to decrease [6] .
However, some resistant bacterial isolates lack an established resistanceconferring mutation, suggesting that unknown mechanisms of resistance remain. Between 10% and 20% of INH-resistant isolates, for instance, lack a mutation in a known resistance gene [7] . Furthermore, other isolates are phenotypically susceptible despite having an established mutation. It is possible that some of this discrepancy may be explained by epistatic interactions (i.e., two or more SNPs may be required to gain drug resistance) or because some of the "established" mutations do not actually cause resistance. These problems motivate further analysis and online predictive systems to provide both improved predictive power for drug resistance and to identify new mechanisms of resistance. Figure 10 .2 Current processing of bacterial pathogens [1] 10.3 Genomic data associated with antibiotic resistance
Overview
Bacterial genetic variation is encoded in two forms: the chromosomal backbone and extrachromosomal plasmids. Both of these are composed of DNA, which consists of long series of nucleotide base pairs: adenine (A), thymine (T), cytosine (C), and guanine (G). Plasmids are small circular rings of DNA that are able to replicate independently from a cell's chromosomal DNA. They often carry drug-resistant and other fitness-enhancing genes. In the process of transcription, portions of DNA are converted into single-stranded RNA. Triplets of RNA bases (codons) are then translated into one of the 20 amino acids, which are building blocks of proteins. The portions of the genome that encode proteins or other functional products are called genes. An SNP is a single-base change in the DNA. SNPs can result in proteins with altered functionality, or, if within a regulatory region, changes in protein production. Our interest here is in relating patterns of SNPs to antibacterial drug resistance.
DNA sequencing
There are several steps to obtain SNP data from a clinical sample. First the DNA must be isolated, next sequenced, then aligned or assembled, and at this point finally SNP is called.
Isolation
After the collection of human blood or sputum samples, the process for obtaining genetic sequence data begins by culturing the bacteria found in the sample. Bacterial colonies are grown up (often 24 h for most bacteria; about 7 days for MTB), after which DNA is extracted, for instance by using the QuickGene DNA Tissue Kit S (Fujifilm, Japan) or the Nextera DNA sample prep kit [8, 9] . This involves the addition of a series of enzymes, together with overnight incubation. The DNA is then randomly fragmented, and adapter sequences are ligated to the fragment ends. This creates multiplexed paired-end DNA libraries, with, for example, an average size of about 200 base pairs [8] .
Sequencing
There are many different sequencing technologies now available. One of the most commonly employed methods is the Illumina HiSeq, which works through sequenceby-synthesis chemistry. DNA is amplified by using solid-phase amplification, which is a clonally amplified template method. DNA binds to random points on the surface of a flow cell (the solid phase), which is covered with a lawn of bound primers. The strands of DNA bind to the primers, a complement DNA strand is formed, and the template strand is washed away. This allows bridge amplification to occur, which is when the single, bound DNA strands flip over to bind to nearby primers. This allows the growth of double-stranded "bridges," which are then denatured to produce a dense cluster of single DNA strands. Amplification produces up to 200 million clusters of DNA strands, each cluster of which may contain thousands of individual strands; the sequence of DNA in each cluster is identical [10, 11] .
Sequencing then commences with four-colour cyclic reversible termination. Here, labelled reversible terminator nucleotides (deoxynucleoside triphosphate (dNTP)), primers, and DNA polymerase are added to the flow cell. The dNTPs bind to corresponding strands and prevent further lengthening. A laser is used to excite the clusters, which emit fluorescence. Four cameras then capture the emitted colour, which allows the first base in each cluster's sequence to be identified. The dNTP is then cleaved, which allows the cycle to be repeated. The sequence is determined based upon the signal intensity of the emitted colour [10, 11] . This process therefore produces thousands of short (e.g., 100-300 base pair), unaligned, overlapping, contiguous "reads" of the DNA sequence, from different locations across the genome.
Sequencing through next-generation platforms promises to be faster and cheaper than current methods. Such platforms are now being commercialised by Pacific Biosciences, Ion Torrent, and Oxford Nanopore, among others [6] . These newer technologies often are able to obtain much longer read lengths than standard methods, which is particularly valuable for untangling the genomic structure for bacteria.
Alignment
Given these thousands of short reads of the DNA sequence from whole-genome sequencing, they must be aligned or assembled into their coherent whole. The sequence reads can be mapped to bacterial chromosome reference sequences using a tool such as Stampy or Maq. Stampy is a sensitive and fast computational tool that maps short DNA reads to a reference using a hybrid mapping algorithm and a statistical model developed at the Wellcome Trust, Oxford [12] . Extrachromosomal DNA such as plasmids are not included in the reference sequences, so resistance genes contained here will not be assembled. Because chromosomal DNA may only represent 20% of the genome for some bacteria, it is therefore necessary to perform de novo assembly for these bacteria in order to obtain information regarding resistance loci both within plasmids and chromosomal DNA. Tools such as Velvet or Newbler can be used for de novo assembly. Velvet removes errors from short read sequences, identifies repeated regions, and uses graphical models to produce assembled DNA contigs [13] .
Calling SNP
A SNP would be called if any individual is heterozygous or homozygous for a nonreference allele. In the case of MTB, the primary sources of genetic variation include point mutations and indels; extra chromosomal plasmids are not involved. Once aligned to the reference, base calls must be made (for instance, using SAMtools). This is the process of determining the most likely base at each position, given all of the reads that mapped to that position. As a form of quality filtering, bases may be recorded as a "nucleotide null call" (i.e., too much uncertainty to call) if the absolute read depth is too low (e.g., fewer than 10 reads at a given location), if the read at a given position is too mixed (e.g., half of the reads are for guanine, and half are for adenine), or if the mapping quality is not high enough. Analysis on genomic data relies crucially on the accurate calling of SNPs. However, SNP calling for low-or moderate-coverage data entails uncertainty. The uncertainty in SNP calling can be improved and quantified by statistical methods, e.g., calculation of quality scores, recalibration of per-base quality scores, likelihood ratio test or Bayesian procedures and lineage disequilibrium-based methods [14] .
Pre-processing
Having assembled a bacterial genome, the next question involves how to capture the relevant information in the form of features. Preparation of the genome feature matrix is a critical pre-processing step for antibiotic resistance prediction.
The pre-processing is commonly consisted three elements: (1) null calls processing; (2) feature translation; and (3) feature reduction.
Null calls processing
A great number of null calls in the obtained SNPs need to be dealt with properly. According to the quality filtering criteria, the SNPs, whose bases are called "null" since the absolute read depth is too low or mapping quality is not high enough, need to be removed or retested. Other null calls due to the highly mixed reads at a given position can be resulted from more than one population of pathogen in one host and the different mutations in these populations. Such SNPs can be properly interpreted in feature matrix according to the desired feature types in the next step.
Feature translation
Two simple ways to convert the DNA sequencing data into features are based on binary variable and reading rate. The most common way to interpret the DNA sequencing data is to use binary variables indicating the presence (==1) or absence (=0) of the corresponding SNP in the isolate. In this case, with respect to an SNP with a null call at a given position caused by mixed reads, the base with the maximum read at this position is called for the SNP. If all three bases are the same with the reference of a codon, it is considered to be an SNP; otherwise, it is not an SNP.
Another way to translate the sequencing data is to compute reading rate for one SNP. The reading rate R is defined as
where Ref i denotes the read of the reference base over the read of all bases at the ith base site of an SNP. Such rate feature is particularly reasonable for the case when the read at a given position is too mixed. Figure 10 .3 illustrates these two ways of feature matrix construction for the sequencing data. The top table shows an example of data source, where Var stands for the obtained base combination for one SNP. The columns of {Ai, Ci, Gi, Ti}, i ∈ [1, 2, 3] provide the reads of four bases at three sites of each SNP. The middle table shows how to represent the SNP with or without the null call in binary case. The bottom table shows how to obtain the reading rate feature.
Feature reduction
All SNPs found on all genes can be extremely huge, which will result in extremely sparse feature matrix. In the preliminary study, it is encouraged to narrow down to those genes highly suspected to be involved in resistance mechanisms. Taken MTB as an example, 23 genes are found to be related to antibiotic resistance. All SNPs found within 23 genes suspected to be involved in resistance mechanisms (a representative selection of which are listed in Table 10 .1 and their 100 base-pair upstream regions were identified. Upstream regions were included so as to capture SNPs that may potentially be involved in gene regulation. The resulting set of 300 SNPs constituted the feature set for subsequent analysis. The average number of SNPs per isolate was 5.0, ranging between 0 and 23. Given different purposes, the features can also be limited to: (i) polymorphisms found on genes already thought to be involved in resistance for a given drug; (ii) polymorphisms that were already suspected to confer drug resistance; and (iii) polymorphisms that were not previously suspected to confer drug resistance. Such reduction for features is not compulsive, yet highly recommended, which will benefit efficient validation of new biomarkers by taking advantage of prior knowledge of microbiology.
Direct association
Direct association (DA) method is a simple algorithm to use prior clinical knowledge and essentially represents the best predictive performance that could be obtained based upon those clinical associations already identified in the literature. For an instance, the list of established Hain mutations and a database of MTB mutations is provided in References 15, 16, we assembled a list of mutations that have been previously associated with resistance in clinical and experimental studies. The loci contained in this list of "established" mutations correspond to locations within the starred genes in Table 10 .1. A simple "OR" rule is applied: if any of the established mutations was present for a given isolate, the isolate was classified as being resistant to that drug.
Supervised models
In this section, we assessed several different supervised classification algorithms for the prediction of isolates as being susceptible or resistant to each of the four firstline drugs. This comparison allowed us to understand how well the assumptions of each (e.g., linear combinations of features; independent features) were substantiated in the data. We examined four machine learning models: logistic regression, support vector machine (SVM), random forest (RF), and Bayesian product of marginals. These supervised models are also termed classifiers in this chapter.
We will consider a subset of N isolates to represent a training set of examples x 1 . . . x N with labels 1 . . . N , ∈ {0, 1}, with 1 indicating drug resistance for a given drug and 0 indicating susceptibility. Each example x i is composed of a vector of D binary features indicating the presence (x ij = 1) or absence (x ij = 0) of a given SNP.
Logistic regression
Logistic regression (LR) is a linear classification method that optimises a set of weights w assigned to each input feature to provide the best classification performance using a training dataset. LR can be formulated by considering the sigmoidal hypothesis function:
which is the probability that the given example is of class 1. An example is assigned to class 1 based upon whether the hypothesis function h(x n ) is greater than or less than a set threshold T . We define a cost function that includes a penalty when the hypothesis is incorrect:
Adding an L 2 regularisation term to discourage the weights from overfitting the data by penalising large values in w, the final equation to be minimised is:
where λ is an adjustable parameter that governs the degree of regularisation. We also examined LR with the "least absolute shrinkage and selection operator" (LASSO) regularisation method, which imposes the constraint that the L 1 norm ||w|| = i |w i | does not exceed some threshold value. From a Bayesian perspective, this is equivalent to putting a zero-mean Laplace prior on the feature weightings, meaning that the prior assumption is that the feature is not important until the training data shows otherwise.
Support vector machine
The SVM is a classification algorithm that attempts to separate two groups by the widest margin possible in some feature space. The hyperplane defining this separation is determined by maximising the distance between it and the closest training points from each class, which are termed the support vectors. Here we will consider a set of labels 1 . . . N , ∈ {−1, 1}, in keeping with the SVM literature.
The formulation of an SVM begins by considering the distance of each training example x i from the hyperplane y(x n ) = w T x n + b, where b is a bias parameter and w is again a vector of weights. This distance is written as
. This is subject to the constraint that y n (w T x n + b) ≥ 1 because the goal is to classify all examples correctly. The data is not always linearly separable, however, which is taken into account through the introduction of a "slack variable" for every training example, ξ n , and a cost parameter, C. The slack variable ξ n = 0 if the example datapoint x n lies on or within its correct boundary, and ξ n = | n − y(x n )| otherwise. The parameter C penalises misclassified examples. C is analogous to a regularisation parameter in that lower values of C correspond to more slowly changing decision boundaries (because misclassifications are not penalised heavily), and vice versa. The constraint is therefore n y(x n ) ≥ 1 − ξ n . As the goal is to maximise the distance between the hyperplane and the closest training example, which requires maximising ||w|| −1 , this is equivalent to minimising ||w|| 2 , where the square is introduced to avoid taking the root in ||w||. This therefore requires the minimisation of f (w) = C N n=1 ξ n + 1 2 ||w|| 2 , which is referred to as the primal form of the classifier. The primal form can be re-written in terms of the feature vectors themselves in the dual form, which requires maximisation of:
where α is another vector of weights, with w = N i=1 α i i x i . 1 The dual form allows for the use of the "kernel trick" to project data into a high-dimensional space, in which the two classes may be linearly separable. The kernel trick is a method by which, rather than using the actual vector of features that define each x n , a kernel function that describes the features of each example in relation to each other is used instead. Through Mercer's theorem, any positive semi-definite kernel function corresponds to a high-dimensional space, for which k(x, x ) = φ(x)φ(x ) and where φ(x) is some mapping from our original data space to the higher-dimensional space. That is, we can avoid operating in the high-dimensional space because we require only the dot product in 10.5, and our kernel function gives the scalar product in that space. The Gaussian radial basis function kernel is one of the most commonly used kernels because of its straightforward interpretation as a similarity metric between two points:
Random forest
RFs are ensemble learners, which means that the RF prediction is based upon the votes of a committee of many weak "base learners." The base learner for an RF is a decision tree, each of which is formed from a random subset of the available features and a random subset of the available training set. After all of the trees have been built, the classifier's prediction is based upon majority voting of the trees. For problems involving genomic loci as features, building 40-400 trees and using a random selection of half of the features has been found to be a suitable means of initialising the various parameters [17] .
Bayesian naive Bayesian (BNB)
Unlike the classifiers described previously, BNB is a generative model, and it assumes that all features are independent. This assumption rarely holds, but BNB nevertheless often produces good classification performance. With our training examples X = {x n } n=1...N , π as the prior probability of being in a class, θ j as the probability that a given feature is "on" (i.e., it has value 1), and again taking 1 with 1 as the indicator function and N c = i 1(y i = c); that is, N c is the number of examples in class c. We could then use a maximum likelihood estimate (which would involve differentiation of the log likelihood, introduction of Lagrange multipliers, and solving for the parameters), but here we will instead obtain full distributions over the model parameters by introducing a set of prior distributions. 2 We will place a Beta(β 0 , β 1 ) prior over each θ jc and a Dirichlet(α) prior for each π. 3 This then leaves us with
where
The BNB approach provides a probability distribution over the probability that an isolate in class c has the given SNP. After training, predictions are made on new data by calculating the probability of the class label, given the new example and the training data. The class label with the highest probability is the final prediction. This probability is formulated as p( = c|x, X ) ∝ p( = c|X ) D j=1 p(x j |y = c, X ). Expanding out, this becomes
withθ jc being the mean value of the fitted parameter distribution, equal to
We used a U-shaped Beta prior, Beta(0.5, 0.5), for every θ jc except for the established SNPs. For these, we used a Beta(1, 0.25) prior for the resistant class, which shifts the prior distribution towards θ jc = 1, and a Beta(0.25, 1) prior for the susceptible class, which shifts the prior distribution towards θ jc = 0, as is illustrated in Figure 10 .4. We used a uniform Dirichlet distribution as a prior over each class. 2 The cumulative distribution function (cdf) is the probability that a given random variable will have a value less than or equal to x, while the probability density function (pdf) is the relative likelihood that a given random variable will take on the value x. The cdf may also be called the "distribution function," while the pdf may also be called the "density." However, the machine learning literature tends to use the word "distribution" to refer to the pdf, as we will in this report. 3 The Beta distribution provides a distribution over the interval [0, 1] . It is parameterised by a > 0 and b > 0, which determine the distribution's shape. The Dirichlet distribution is distributed over K random variables and has a single K-dimensional parameter, α > 0. The beta distribution is a special case of the Dirichlet distribution, in which K = 2. 
Supervised classification for antibiotic resistance prediction
This part addresses the framework of using supervised models to predict antibiotic resistance, which in essence is supervised classification. Figure 10 .5 illustrates the procedure of supervised classification for antibiotic resistance. Validation of supervised classifiers for antibiotic resistance prediction is consisted of three steps: (1) assembling balanced dataset; (2) training the supervised model; (3) testing the model.
Assembling balanced datasets
Usually, there are many more susceptible isolates than resistant isolates. To avoid bias in the classifier, it is recommended to construct balanced datasets. Taken one data source of MTB as an example, of the 1835 isolates, only 266, 97,47, and 59 isolates were resistant to INH, RIF, EMB, and PZA, respectively. Therefore, to assemble a balanced dataset for training a classifier, a subset of susceptible isolates equal to the number of resistant isolates is randomly selected, for example, for INH analysis, 266 susceptible isolates are selected. In each obtained balanced dataset, the resistant isolates are the same while the susceptible isolates are different. Then, each model can be trained on 80% of this balanced dataset and tested on the held-out 20%.
Training a classifier
The parameters of these supervised models, e.g., width of SVM kernel, soft margin of SVM, and the regularisation parameter of LR, should be determined based on internal fivefold cross-validation on 80% of training data. These optimised parameters will then be used train a final model using all the training data, meanwhile, the decision threshold is determined by maximising the classification performance.
Testing a classifier
The final obtained model after the training stage is used for prediction on the "heldout" 20% data in the test set. This process can be repeated for many times with each time random samplings from the pool of susceptibility examples. Ultimately, the mean and standard deviation of the accuracy, sensitivity, and specificity can be subsequently calculated across all iterations, allowing an assessment of the variation in the process due to the stochastic selection of the training and testing data. These results also provide a fair comparison among all available models as well as the DA method.
Unsupervised models
Unsupervised learning is used to cluster objects when they are given without associating labels, which is promising as an exploratory tool for discovering hidden structures of the dataset, and especially useful to examine whether there are new, undetected groups of similar samples within the dataset. It has played a crucial role in the analysis of gene expression data. The nature basis for organising gene expression data is to group together genes with similar patterns of expression. Ongoing antibiotics resistance analysis using unsupervised learning is limited and challenged, mainly because the mechanism of antibiotics resistance of the pathogen still needs to be well understood. Unsupervised learning is promising given the uncertainty of phenotype test. Sometime, phenotypic testing has proved to be unreliable in some well-described situations. For example, the susceptibility tests are subject to many assumptions about the degree of susceptibility based on the minimum inhibitory concentration (MIC), and they require the selection of a "breakpoint" for each antibiotic: an MIC level above which the isolate is deemed to be resistant to therapy. These breakpoints are chosen on the basis of diverse but imperfect factors. There is considerable debate on how to set the breakpoints, and these are not always agreed across countries and organisations. The effect of susceptibility testing on the clinical response to infection is difficult to study, given the multiple factors that influence patient outcome, so that the sensitivity and specificity for determining resistance or susceptibility of phenotypic tests are often poorly measured.
Unsupervised clustering methods that are potentially usable for analysing genomic data in infectious disease management will be focused in the section. Typical clustering is consisted of discriminative and generative models. K-means clustering, as non-probabilistic model, is a representative of discriminative models. Generative model in an unsupervised fashion is often termed latent variable model which assumes the data is generated by unseen variables. The variables to be discovered can be latent feature, latent cause or latent class. We will introduce two typical unsupervised models: mixture model and latent feature model.
In this section, we will consider a subset of N isolates to represent a training set of examples X = {x 1 . . . x N } only without phenotypic labels. Both the binary and percentage representation of genomic data are considered. For example, each example x i can be composed of a vector of D binary features indicating the presence (x ij = 1) or absence (x ij = 0) of a given SNP j, or, a vector of percentage features indicating the probability of being a mutation for the given SNP.
Mixture model
Instead of assigning hard label to examples, mixture models tend to associate an example with the probability of mixture components responsible for generating the example. A mixture model, also termed latent class model, assumes each example in a component c i with probability
which is a multinomial and π k is prior or mixing weights of the kth component. In the mixture model, the probability of the assignment satisfies
The assignment is the latent variable to be estimated. To model the probability of the data with the latent variable is to marginalise likelihood with the probability of being in a class,
where for each component k, p(x i |c i = k, θ ) is component-conditional probability (density) function. θ is the parameters of the mixture components. This can be seen as a generative model that first selects the kth component with probability p(c i = k) and then generates x i in accordance with p(x i |c i = k, θ ). Note that (10.11) assumes an upper bound on the number of mixture components, since it only allows assignments of objects up to K clusters.
For such a mixture model, the maximise likelihood estimation (MLE) cannot be solved since the derivative of the log likelihood of the model with summation in the log cannot be computed explicitly. Expectation maximisation (EM) is often preferred for finding MLE estimates of mixture models because of its simplicity. In the E-step, the current model values are used to evaluate the posterior of the latent variable p(C|X; θ old ), termed responsibility. Then, in the M-step, the model parameters is re-estimated using the current responsibility, the objective function of this step is,
which is to maximise the expectation of the ln p(C, X|θ) with respect to C drawn according to the distribution given by p(C|X; θ old ). The EM procedure is similar to the iterative update in the K-means. The update iterates as: (1) assign every data point to pre-defined cluster with probability; (2) update cluster using the assigned data points.
Any conditional density to model each cluster in each cluster. In particular, the use of the Bernoulli mixture model (BMM) is discussed below. BMM is used to model the probability distribution of binary data. A Bernoulli model is a particular case of (10.11), where each component k has D-dimensional Bernoulli probability function governed by its own vector of parameters or prototype
The parameters of mixture component in BMM is θ = {π k , μ k }. Note that (10.13) is just the product of independent, unidimensional Bernoulli probability functions. Therefore, for a fixed k, it cannot capture any kind of dependencies or correlations between individual SNP. Unlike a single product of Bernoulli, the mixture distribution can capture correlations between variables. Using mixture models for antibiotic resistance, prediction is based on the assumption that the population of resistant isolates with respect to one specific antibiotic usually includes MDR isolates and isolates that are resistant to other drugs. The mixture model for modelling data given the label is called class-conditioned mixture model or mixture discriminant analysis, which is to model the conditional density of each class. To model the genomic data, given the phenotype using class-conditioned mixture model is to train mixture model with respect to the resistant and susceptible isolates, respectively.
Then, the optimal Bayes decision rule is to assign each example x to a class * (x) giving maximum a posteriori probability or, equivalently, * (x) = argmax log p( ) + log p(x| ) (10.15) Figure 10 .6 illustrates the class-conditioned mixture model in antibiotic resistance prediction given the class labels in terms of INH. It shows that there are multiple mixture components in both classes, which either relate to the subgroup of isolates with different phenotype profile for all tested antibiotic drugs or relate to different lineages of isolates. According to the established model, one can also inference the pattern of the mixture component that is most likely responsible for every isolate. The misclassified isolates could either be mislabelled or be resistant to other drugs except for INH. Noted that black area means that isolates of lineage 4 labelled by resistant class have same pattern with that lineage in susceptible class, which could be mislabelled.
Bayesian mixture model
In real practice, we don't really believe there is a "true" number of clusters, which motives the application of non-parametric Bayesian mixture models, or infinite mixture model. Such model assumes that the data comes from a mixture of an infinite number of distributions, which means to specify the probability of X in terms of infinitely many classes.
The Bayesian approach offers an appealing strategy, which is to allow an "infinite" (i.e., unbounded) number of mixture components. A merit of infinite mixture model is as the dataset gets larger and more heterogeneous, the number of components grows automatically. One scheme to develop infinite mixture models is to apply prior distribution on the mixing weight and to take limit of analytic marginal distribution as the number of class approaches infinity.
Specifically, in Bayesian approaches to mixture modelling, mixing weights π is assumed to follow a prior distribution p(π), with a standard choice being a symmetric Dirichlet distribution. The Dirichlet distribution on multinomials over K classes has parameters α 1 , α 2 , . . . α K , and is conjugate to the multinomial. In a symmetric Dirichlet distribution, all α k are equal, which take α k = α K for all k. The probability model of the Dirichilet-multinomial model is (10.16) where Discrete(π ) is the multiple-outcome analogue of a Bernoulli event. The marginal probability of an assignment vector c, integrating over all values of π is, (10.17) where
is the number of objects assigned to class k. Considering two assignment vectors that result in the same division of objects correspond to the same partition, we denote [c] as an equivalence class of assignment vectors. The probability of each equivalence class assignments is (10.18) where K + is the number of classes for which m k > 0, K 0 is the number of classes for which m k > 0, so K = K 0 + K + . Rearrange the first two terms, we can compute the limit of the probability of a partition as K → ∞, which is
A simple process that produces the same distribution over partitions specified above is Chinese restaurant process (CRP). Figure 10 .7 illustrates the generative process for CRP, where each observed example is assigned to one The introduction of Bayesian mixture model shows that infinite statistical models can be defined by specifying priors over infinite combinatorial objects, which can be derived by taking the limit of priors for finite models. Although the large hypothesis spaces are implied, the inference in these models can remain possible. Infinite mixture models are still fundamentally limited in their representation of objects, assuming that assume each example can only belong to a single class.
Latent feature model
Unlike mixture model, latent feature model assumes the multiple latent features are responsible for generating each object. In another word, it assumes that each object belongs to multi-classes simultaneously. Latent feature models are known for dimension reduction. Typical latent feature models include factor analysis, principal component analysis, cooperative vector quantisation, etc.
In a latent feature model, each object is represented by latent feature values f i , and the properties x i are generated from a distribution determined by those latent feature values. Latent feature model is to represent objects in terms of latent features values Then, break matrix F into two components as, F = Z ⊗ V,where Z defines which features are processed by each object, V stores value of each feature for each object, ⊗ denotes elementary product and Z contains the information about the latent feature.
As using Bayesian approach to obtain the infinite mixture model, define a prior for infinite latent feature models is to define a distribution over infinite binary matrices Z. The prior is defined as The probability mode of the data is derived as marginal probability as,
Similar to the infinite mixture model, consider the limit of analytic marginal distribution as the number of latent features approaches infinity.
This distribution over partitions provides a prior over class assignments matrices for an infinite feature model. The equivalent stochastic process to obtain the same distribution is termed Indian buffet process (IBP). Interested readers can refer to Reference 19 for sampling from the distribution defined by IBP. Figure 10 .8 illustrates the generative process for IBP, where each observed example possesses multiple dishes (features) and the number of dishes is unbounded. Also noted that in the latent feature model, the obtained features are shared by all observations. Combining this prior with Gaussian likelihood, the linear Gaussian latent feature model is given by, The dependencies among the variables in this model are shown in Figure 10 .9. The inference of other hyper-parameters relies on Monte Carol Markov Chain (MCMC). Within each iteration of MCMC, the IBP is sampled with straightforward Gibbs sampling. The inference based on MCMC for Bayesian latent feature models is time consuming especially for genomic data of infectious disease pathogen. Variational inference can be an alternative option to fulfil the task of antibiotics resistance prediction. The underlying assumption of the latent feature model matches the hidden structure of the genomic data, which implies great potential of this type of models for modelling genomic data for antibiotic resistance prediction and infectious disease management.
Summary
In the infectious disease management, accurate antibiotic resistance prediction using genomic data of pathogen will shorten the treatment significantly. Both supervised and unsupervised machine learning in this task have shown valuable merits to date.
Developing more robust machine learning methods is desired, given the following reasons:
1. When evaluating the predictive performance of a machine learning system, it is necessary to keep in mind that the analysis operates upon statistical associations across the input features. Improved prediction can be due to the discovery of new resistance-conferring mutations, epistatic interactions between mutations that together cause resistance, phylogenetic associations, or the fact that isolates are commonly resistant to multiple drugs. 2. Machine learning can be used in many of the steps of clinical infectious disease management and resistance prediction. Considering increasingly more coming sequencing data and limited phenotype labels, the merits of semi-supervised and unbounded latent variable model is promising for infectious disease management and resistance prediction in the future. 3. To make full use of genomic data, unbalanced case needs to be considered. Unbalance data is one of the key concerns in machine learning community, which highly affects the performance of one classifier. In classification, machine learning algorithms will suffer a performance bias when datasets are unbalanced. Increasing the accuracy of minority class can result in lower accuracy on majority class. To overcome the bias, various solutions are available, that is, multiobjective optimisation [20] , over-and under-sampling [21] , adaptive evaluation measurement [22] , etc. 4. A human error is always possible in lab based susceptible test and an error in the phenotype could have big effects on the decision phase, particularly if the size of the learning example is small. It is therefore very important to provide supervised classifiers robust enough to deal with data with uncertain labels. 5. Cross-resistance phenomena, also termed resistance co-occurrence, have been frequently found in MTB, e.g., MTB that are resistant to PZA are more likely to be resistant to INH as well. Machine learning techniques should take crossresistance information explicitly into account to improve classification and prediction of drug resistance.
In addition, any promising mutations must be validated through additional experimental analysis before being deemed as causative. For instance, it is very easy to find highly predictive mutations of MTB for PZA drug resistance simply because MTB that are resistant to PZA are more likely to be resistant to INH as well. This can lead to the incorrect conclusion that INH-causative mutations are mechanistically involved in PZA drug resistance. This does not necessarily limit the benefit of the learned association (indeed, this is an intuition that doctors have developed as well when designing a drug regimen for patients), but it does mean that a predictive system should be continually updated to adapt to a changing bacterial population.
